|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||
| Net loss | |||
| Adjustments required to reconcile net loss to net cash used in operating activities: | |||
| Depreciation | |||
| Loss on disposal of property and equipment | |||
| Stock based compensation | |||
| Interest expenses with respect to funding from related party | |||
| Change in fair value of convertible loan | |||
| Changes in fair value of derivative liabilities | |||
| Issuance expenses attributable to derivative warrant liabilities | |||
| Inventory write-down | |||
| Finance expenses | |||
| Loss (gain) from exchange differences on cash and equivalents | |||
| Changes in operating assets and liabilities: | |||
| Trade receivables, net | |||
| Other current assets | |||
| Prepaid expenses, net of current portion | |||
| Prepaid expenses | |||
| Inventories | |||
| Operating lease right-of-use asset | |||
| Trade payables | |||
| Operating lease liabilities | |||
| Other accounts payable | |||
| Other current liabilities | |||
| Net cash used in operating activities | |||
| CASH FLOWS FROM INVESTING ACTIVITIES: | |||
| Change in restricted deposit | |||
| Purchase of property and equipment | |||
| Investment in short term deposits | |||
| Net cash used in investing activities | |||
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||
| Issuance of ordinary shares in initial public offering, net of issuance costs (Note 9c) | |||
| Issuance of ordinary shares, pre-funded warrants and warrants in private placement, net of issuance costs (Note 9b) | |||
| Proceeds from exercise of series A warrants (Note 10b) | |||
| Issuance of ordinary shares in initial public offering, net of issuance costs (Note 10c) | |||
| Issuance of ordinary shares, pre-funded warrants and warrants in private placement, net of issuance costs (Note 10f and 10g) | |||
| Receipt of loan from related party | |||
| Repayment of loan from related party | |||
| Net cash provided by financing activities | |||
| Net (decrease) increase in cash and cash equivalents | |||
| Effect of exchange rate changes on cash, cash equivalents | |||
| Net increase (decrease) in cash and cash equivalents | |||
| Cash and cash equivalents at beginning of the year | |||
| Cash and cash equivalents at the end of the year | |||
| Supplementary disclosure on cash flows: | |||
| Cash paid for interest | |||
| Cash received from interest | |||
| Supplemental disclosure of non-cash investment and financing activities: | |||
| Right-of-use assets obtained in exchange for operating lease liabilities | |||
| Benefit to the Company by an equity holder with respect to funding transactions | |||
| Conversion of convertible notes into ordinary shares | |||
| Stock based compensation included as issuance costs | |||
| Exercise of liability classified warrants into ordinary shares |
Loading...